[Enhancing utero-placental blood flow with EPH-gestosis patients through long-term therapy with beta-sympathomimetica (author's transl)].
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007204:Indium; D008134:Long-Term Care; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D009921:Metaproterenol / Q000627:therapeutic use; D008722:Methods; D010920:Placenta / Q000098:blood supply*; D010922:Placenta Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D011247:Pregnancy; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012039:Regional Blood Flow / Q000187:drug effects; D013667:Technetium
D000318:Adrenergic beta-Agonists; D011868:Radioisotopes; D007204:Indium; D009921:Metaproterenol; D013667:Technetium
Uteroplazentare Durchblutungsverbesserung bei EPH-Gestose durch Langzeit-Therapie mit Beta-Sympathikomimetika